In addition, SSc serum has been reported to contain anti-endothelial cell antibodies that may induce endothelial cell apoptosis [43–45] and anti-fibrillin-1 antibodies that may alter the interaction of endothelial cells with the surrounding extracellular matrix [46,47]. Here, FBN1 is linked to systemic sclerosis.